DeltaGen Inc. (DGEN)
Market Closed
11 Aug, 20:00
OTC GREY OTC GREY Primary 
LSE $
0. 00
0
0%
$
3.86K Market Cap
0 P/E Ratio
0.2% Div Yield
442,968 Volume
0 Eps
$ 0
Previous Close Want to track DGEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
DGEN closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, DGEN stock gained 0%.
DGEN pays dividends to its shareholders, with the most recent payment made on May 31, 2007. The next estimated payment will be in 31 May 2008 on May 31, 2008 for a total of $0.05.
The last earnings report, released on Dec 31, 2014, exceeded the consensus estimates by 0.0023%. On average, the company has surpassed earnings expectations by 0.0022%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC GREY (USD).
DeltaGen Inc. (DGEN) FAQ
What is the stock price today?
The current price is $0.00.
On which exchange is it traded?
DeltaGen Inc. is listed on OTC GREY.
What is its stock symbol?
The ticker symbol is DGEN.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.2%.
What is its market cap?
As of today, the market cap is 3.86K.
Has DeltaGen Inc. ever had a stock split?
No, there has never been a stock split.
DeltaGen Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Robert J. Driscoll CEO | OTC GREY Exchange | 24783R103 CUSIP |
| US Country | - Employees | 31 May 2007 Last Dividend | - Last Split | 3 Aug 2000 IPO Date |
Overview
Deltagen Inc. is a pioneering entity in the biopharmaceutical sector, specializing in the provision of crucial drug discovery tools and services. Founded in 1999 and operating from its headquarters in San Mateo, California, the company has cemented its reputation as a key partner for pharmaceutical companies by offering advanced solutions aimed at streamlining the drug discovery process. Deltagen Inc. distinguishes itself with a strong focus on increasing the efficiency of drug discovery through its innovative programs and technologies, all while emphasizing target validation in critical health areas such as immunology and metabolic diseases.
Products and Services
Deltagen Inc. offers an array of products and services designed to expedite and optimize the drug discovery process for its clients. These offerings include:
- Biological Models: Deltagen provides access to a variety of genetically engineered animal models. These models are invaluable for preclinical studies, allowing researchers to study disease mechanisms, assess drug efficacy, and investigate safety profiles in systems that mimic human diseases.
- Small-molecule Drug Targets: Recognizing the importance of identifying and validating novel drug targets, Deltagen offers a suite of services dedicated to small-molecule drug targets. This includes the identification of potential targets and the development of assays to test small-molecule interactions, contributing significantly to the early stages of drug discovery.
- Secreted Protein Drug Targets: Alongside small-molecule targets, Deltagen also specializes in the identification and validation of secreted protein drug targets. Such proteins often play crucial roles in signaling pathways and represent an important class of therapeutics, particularly in the areas of immunology and metabolic diseases.
- Target Validation Data: A core component of Deltagen's offerings is its target validation services. By providing comprehensive data on the function and disease relevance of potential drug targets, the company empowers its clients to make informed decisions during the drug development process. This is especially pertinent in the fields of immunology and metabolic diseases, where the correct identification of targets can significantly impact the success rate of new therapies.
Contact Information
Address: 1900 South Norfolk Street
Phone: 650-345-7601
Website: https://www.d-gen.co.il
